Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

46
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
46
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

44
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
44

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attention and learning strategies reveal distinct dimensions of psychiatric diseases.

Research square·2026
Same author

Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder.

Nature communications·2026
Same author

QuNex recipes: Executable, human-readable workflows for reproducible neuroimaging research.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Toward trustworthy clinical AI for obsessive-compulsive disorder: reliability, generalizability, and interpretability of a transformer model across the ENIGMA-OCD consortium.

medRxiv : the preprint server for health sciences·2026
Same author

A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns - CORRIGENDUM.

Psychological medicine·2026
Same author

Disrupted Higher-Order Topology in OCD Brain Networks Revealed by Hodge Laplacian - an ENIGMA Study.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 7, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.1K

Functional Connectivity Biomarkers in Schizophrenia.

Amber M Howell1, Alan Anticevic2

  • 1Yale University, School of Medicine, New Haven, CT, USA.

Advances in Neurobiology
|November 19, 2024
PubMed
Summary

Functional connectivity (FC) metrics derived from magnetic resonance imaging (MRI) show promise as biomarkers for schizophrenia, aiding in patient stratification and treatment prediction. Further development is needed to align these neural findings with FDA-NIH biomarker categories.

More Related Videos

Dynamic Inter-subject Functional Connectivity Reveals Moment-to-Moment Brain Network Configurations Driven by Continuous or Communication Paradigms
08:36

Dynamic Inter-subject Functional Connectivity Reveals Moment-to-Moment Brain Network Configurations Driven by Continuous or Communication Paradigms

Published on: March 21, 2019

7.2K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

14.8K

Related Experiment Videos

Last Updated: Jun 7, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.1K
Dynamic Inter-subject Functional Connectivity Reveals Moment-to-Moment Brain Network Configurations Driven by Continuous or Communication Paradigms
08:36

Dynamic Inter-subject Functional Connectivity Reveals Moment-to-Moment Brain Network Configurations Driven by Continuous or Communication Paradigms

Published on: March 21, 2019

7.2K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

14.8K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biomarker Development

Background:

  • Schizophrenia affects 1% of the population, presenting a significant public health challenge.
  • Current treatments are limited due to incomplete understanding of neural mechanisms.
  • No FDA-approved biomarkers exist for psychiatric disorders like schizophrenia.

Purpose of the Study:

  • To review studies using MRI-derived functional connectivity (FC) in schizophrenia.
  • To assess the alignment of FC metrics with FDA-NIH biomarker categories.
  • To outline challenges and goals for developing FC biomarkers.

Main Methods:

  • Review of magnetic resonance imaging (MRI)-based studies.
  • Analysis of functional connectivity (FC) data measuring brain region interactions.
  • Correlation of neural changes with clinical symptoms and treatment response.

Main Results:

  • MRI-based FC studies have identified abnormal brain function patterns in schizophrenia.
  • FC metrics have differentiated patient subgroups and predicted antipsychotic medication response.
  • FC alterations correlate with schizophrenia symptoms.

Conclusions:

  • Functional connectivity (FC) metrics show potential as biomarkers for schizophrenia.
  • FC biomarkers could improve patient stratification and treatment selection.
  • Further research is required to establish validated FC biomarkers aligned with regulatory standards.